The National Medical Products Administration (NMPA) has approved two innovative medical devices in China: Ningbo Senscure Biotechnology Co., Ltd’s disposable cryoablation balloon catheter and Suzhou Kangduo Robot Co., Ltd’s laparoscopic surgery system. These approvals mark significant advancements in their respective medical fields.
Senscure’s Cryoablation Balloon Catheter
Senscure’s device comprises a balloon, catheter body, and handle, designed for adjuvant cryoablation therapy in adult patients with stage T1 non-muscle invasive bladder cancer (NMIBC) following the initial transurethral resection of bladder tumor (TURBt). As the first bladder tumor cryotherapy medical device in China, it boasts a first-in-class operating principle and intellectual property protection.
Kangduo’s Laparoscopic Surgery System
Kangduo’s system includes a doctor’s console, patient operating table, surgical instruments, and accessories for upper urinary tract laparoscopic surgery. Doctors can control 3D endoscopes and instruments via a controller and foot pedal, enhancing surgical flexibility, precision, and safety while reducing costs compared to imported products.-Fineline Info & Tech
